FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations
Committee reviewed clinical data showing a booster dose of COMIRNATY® elicits high neutralization titers against…